Real-time enrollment status for this type 2 diabetes clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 6:06 AM UTC
| NCT Number | NCT06739122 |
| Recruiting Status | Recruiting |
| Condition | Type 2 Diabetes |
| Phase | PHASE3 |
| Target Enrollment | 55 participants |
| Active Locations | 41 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | June 18, 2026 (Jun 18, 2026) |
As of July 18, 2026: Clinical trial NCT06739122 is currently recruiting participants. This phase3 study for type 2 diabetes is actively seeking new participants at 41 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06739122 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 41 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06739122 was last updated Jun 18, 2026 (June 18, 2026). HelloStudys verifies this status automatically.